The co-evolution of host cationic antimicrobial peptides and microbial resistance (original) (raw)

• Woolhouse, M. E., Webster, J. P., Domingo, E., Charlesworth, B. & Levin, B. R. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nature Genet. 32, 569–577 (2002).
  CAS PubMed Google Scholar
• Grenfell, B. T. et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303, 327–332 (2004).
  CAS PubMed Google Scholar
• Brubaker, R. R. The recent emergence of plague: a process of felonious evolution. Microb. Ecol. 47, 293–299 (2004).
  CAS PubMed Google Scholar
• Waldvogel, F. A. Infectious diseases in the 21st century: old challenges and new opportunities. Int. J. Infect. Dis. 8, 5–12 (2004).
  PubMed Google Scholar
• Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389–395 (2002). This is a comprehensive review on the diversity, structure, activity and possible applications of endogenous antimicrobial peptides from higher organisms.
  CAS PubMed Google Scholar
• Hancock, R. E. W. & Diamond, G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8, 402–410 (2000).
  CAS PubMed Google Scholar
• Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nature Rev. Immunol. 3, 710–720 (2003).
  CAS Google Scholar
• Lehrer, R. I. Primate defensins. Nature Rev. Microbiol. 2, 727–738 (2004).
  CAS Google Scholar
• Brogden, K. A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Rev. Microbiol. 3, 238–250 (2005).
  CAS Google Scholar
• Selsted, M. E. & Ouellette, A. J. Mammalian defensins in the antimicrobial immune response. Nature Immunol. 6, 551–557 (2005).
  CAS Google Scholar
• Dorschner, R. A. et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 20, 35–42 (2006).
  CAS PubMed Google Scholar
• Sahl, H. G. et al. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77, 466–475 (2005). This article compares the antibacterial and membrane-disrupting properties of mammalian defensins.
  CAS PubMed Google Scholar
• Yang, D., Biragyn, A., Kwak, L. W. & Oppenheim, J. J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23, 291–296 (2002).
  CAS PubMed Google Scholar
• Bals, R. & Wilson, J. M. Cathelicidins — a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 60, 711–720 (2003).
  CAS PubMed Google Scholar
• Bowdish, D. M. et al. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77, 451–459 (2005).
  CAS PubMed Google Scholar
• Dürr, M. & Peschel, A. Chemokines meet defensins — the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect. Immun. 70, 6515–6517 (2002).
  PubMed PubMed Central Google Scholar
• Rosenfeld, Y., Papo, N. & Shai, Y. Endotoxin (LPS) neutralization by innate immunity host-defense peptides: peptides' properties and plausible modes of action. J. Biol. Chem. 281, 1636–1643 (2006).
  CAS PubMed Google Scholar
• Vallender, E. J. & Lahn, B. T. Positive selection on the human genome. Hum. Mol. Genet. 13,R245–R254 (2004).
• Patil, A., Hughes, A. L. & Zhang, G. Rapid evolution and diversification of mammalian α-defensins as revealed by comparative analysis of rodent and primate genes. Physiol. Genomics 20, 1–11 (2004).
  CAS PubMed Google Scholar
• Nusbaum, C. et al. DNA sequence and analysis of human chromosome 8. Nature 439, 331–335 (2006).
  CAS PubMed Google Scholar
• Crovella, S. et al. Primate β-defensins — structure, function and evolution. Curr. Protein Pept. Sci. 6, 7–21 (2005). This article describes the diversity of defensin structures in primate species.
  CAS PubMed Google Scholar
• Nizet, V. in Antimicrobial Peptides in Human Health and Disease (ed. Gallo, R. L.) 277–304 (Horizon Bioscience, Norfolk, 2005).
  Google Scholar
• Peschel, A. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10, 179–186 (2002).
  CAS PubMed Google Scholar
• Kraus, D. & Peschel, A. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr. Top. Microbiol. Immunol. 306, 231–250 (2006).
  CAS PubMed Google Scholar
• Kristian, S. A. et al. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J. Infect. Dis. 188, 414–423 (2003).
  CAS PubMed Google Scholar
• Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454–457 (2001). This article demonstrates the important role of CAMPs in host defence using transgenic mice lacking the murine homologue of LL-37.
  CAS PubMed Google Scholar
• Gunn, J. S., Ryan, S. S., Van Velkinburgh, J. C., Ernst, R. K. & Miller, S. I. Genetic and functional analysis of a PmrA–PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar Typhimurium. Infect. Immun. 68, 6139–6146 (2000).
  CAS PubMed PubMed Central Google Scholar
• Weidenmaier, C. et al. DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect. Immun. 73, 8033–8038 (2005).
  CAS PubMed PubMed Central Google Scholar
• Kramer, N. E., van Hijum, S. A. F. T., Knol, J., Kok, J. & Kuipers, O. Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrob. Agents Chemother. 50, 1753–1761 (2006).
  CAS PubMed PubMed Central Google Scholar
• Perron, G. G., Zasloff, M. & Bell, G. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273, 251–256 (2006). This article demonstrates that bacteria can become spontaneously resistant to endogenous antimicrobial peptides on in vitro exposure to slowly increasing peptide concentrations.
  CAS PubMed Google Scholar
• Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nature Med. 10, S122–S129 (2004).
  CAS PubMed Google Scholar
• Chambers, H. F. Community-associated MRSA — resistance and virulence converge. N. Engl. J. Med. 352, 1485–1487 (2005).
  CAS PubMed Google Scholar
• Foster, T. J. The Staphylococcus aureus 'superbug'. J. Clin. Invest. 114, 1693–1696 (2004).
  CAS PubMed PubMed Central Google Scholar
• Andres, E. & Dimarcq, J. L. Cationic antimicrobial peptides: update of clinical development. J. Intern. Med. 255, 519–520 (2004).
  CAS PubMed Google Scholar
• Mygind, P. H. et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437, 975–980 (2005).
  CAS PubMed Google Scholar
• Sieprawska-Lupa, M. et al. Degradation of human antimicrobial peptide LL-37 by _Staphylococcus aureus_-derived proteinases. Antimicrob. Agents Chemother. 48, 4673–4679 (2004).
  CAS PubMed PubMed Central Google Scholar
• Guina, T., Yi, E. C., Wang, H., Hackett, M. & Miller, S. I. A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to α-helical antimicrobial peptides. J. Bacteriol. 182, 4077–4086 (2000).
  CAS PubMed PubMed Central Google Scholar
• Nyberg, P., Rasmussen, M. & Bjorck, L. α2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J. Biol. Chem. 279, 52820–52823 (2004).
  CAS PubMed Google Scholar
• Schmidtchen, A., Frick, I. M., Andersson, E., Tapper, H. & Bjorck, L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46, 157–168 (2002).
  CAS PubMed Google Scholar
• Wu, Z. et al. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3. Proc. Natl Acad. Sci. USA 100, 8880–8885 (2003). This article analyses different structural requirements for antimicrobial or chemotactic activity of CAMPs.
  CAS PubMed PubMed Central Google Scholar
• Maemoto, A. et al. Functional analysis of the α-defensin disulfide array in mouse cryptdin-4. J. Biol. Chem. 279, 44188–44196 (2004).
  CAS PubMed Google Scholar
• Campopiano, D. J. et al. Structure–activity relationships in defensin dimers: a novel link between β-defensin tertiary structure and antimicrobial activity. J. Biol. Chem. 279, 48671–48679 (2004).
  CAS PubMed Google Scholar
• Rozek, A., Powers, J. P., Friedrich, C. L. & Hancock, R. E. Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry 42, 14130–14138 (2003).
  CAS PubMed Google Scholar
• Harwig, S. S. et al. Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur. J. Biochem. 240, 352–357 (1996).
  CAS PubMed Google Scholar
• Hornef, M. W., Putsep, K., Karlsson, J., Refai, E. & Andersson, M. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nature Immunol. 5, 836–843 (2004). This article describes how the formation of heterodimers by murine CRS peptides leads to multiple antimicrobial molecules with different activity spectra.
  CAS Google Scholar
• Tang, Y. Q. et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science 286, 498–502 (1999).
  CAS PubMed Google Scholar
• Jack, R. W., Bierbaum, G. & Sahl, H.-G. Lantibiotics and Related Peptides (Springer, Berlin, 1998).
  Google Scholar
• Cotter, P. D., Hill, C. & Ross, R. P. Bacteriocins: developing innate immunity for food. Nature Rev. Microbiol. 3, 777–788 (2005).
  CAS Google Scholar
• Tjabringa, G. S. et al. Host defense effector molecules in mucosal secretions. FEMS Immunol. Med. Microbiol. 45, 151–158 (2005).
  CAS PubMed Google Scholar
• Jin, T. et al. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172, 1169–1176 (2004).
  CAS PubMed Google Scholar
• Frick, I. M., Akesson, P., Rasmussen, M., Schmidtchen, A. & Bjorck, L. SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J. Biol. Chem. 278, 16561–16566 (2003).
  CAS PubMed Google Scholar
• Shafer, W. M., Qu, X.-D., Waring, A. J. & Lehrer, R. I. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl Acad. Sci. USA 95, 1829–1833 (1998). This article describes the first multiple drug resistance protein involved in CAMP resistance.
  CAS PubMed PubMed Central Google Scholar
• Tzeng, Y. L. et al. Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 187, 5387–5396 (2005).
  CAS PubMed PubMed Central Google Scholar
• Fernie-King, B. A., Seilly, D. J. & Lachmann, P. J. The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human β-defensins. Immunology 111, 444–452 (2004).
  CAS PubMed PubMed Central Google Scholar
• Douglas, S. E., Gallant, J. W., Liebscher, R. S., Dacanay, A. & Tsoi, S. C. Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish. Dev. Comp. Immunol. 27, 589–601 (2003).
  CAS PubMed Google Scholar
• Park, C. H., Valore, E. V., Waring, A. J. & Ganz, T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276, 7806–7810 (2001).
  CAS PubMed Google Scholar
• Ouellette, A. J. & Selsted, M. E. Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J. 10, 1280–1289 (1996).
  CAS PubMed Google Scholar
• Eckmann, L. Defence molecules in intestinal innate immunity against bacterial infections. Curr. Opin. Gastroenterol. 21, 147–151 (2005).
  CAS PubMed Google Scholar
• Taudien, S. et al. Polymorphic segmental duplications at 8p23.1 challenge the determination of individual defensin gene repertoires and the assembly of a contiguous human reference sequence. BMC Genomics 5, 92 (2004).
  PubMed PubMed Central Google Scholar
• Ernst, R. K., Guina, T. & Miller, S. I. Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 3, 1327–1334 (2001).
  CAS PubMed Google Scholar
• Neuhaus, F. C. & Baddiley, J. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67, 686–723 (2003).
  CAS PubMed PubMed Central Google Scholar
• Peschel, A. et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins and other antimicrobial peptides. J. Biol. Chem. 274, 8405–8410 (1999). This article describes CAMP resistance by alterations of the Gram-positive cell envelope, paralleling lipid A modifications in Gram-negative bacteria.
  CAS PubMed Google Scholar
• Abachin, E. et al. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 43, 1–14 (2002).
  CAS PubMed Google Scholar
• Poyart, C. et al. Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol. Microbiol. 49, 1615–1625 (2003).
  CAS PubMed Google Scholar
• Kristian, S. A. et al. D-alanylation of teichoic acid promotes group A Streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 187, 6719–6725 (2005).
  CAS PubMed PubMed Central Google Scholar
• Peschel, A. et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193, 1067–1076 (2001).
  CAS PubMed PubMed Central Google Scholar
• Weidenmaier, C., Kristian, S. A. & Peschel, A. Bacterial resistance to antimicrobial host defenses — an emerging target for novel antiinfective strategies? Curr. Drug Targets 4, 643–649 (2003).
  CAS PubMed Google Scholar
• Miller, S. I., Ernst, R. K. & Bader, M. W. LPS, TLR4 and infectious disease diversity. Nature Rev. Microbiol. 3, 36–46 (2005).
  CAS Google Scholar
• Koprivnjak, T., Peschel, A., Gelb, M. H., Liang, N. S. & Weiss, J. P. Role of charge properties of bacterial envelope in bactericidal action of human Group IIA phospholipase A2 against Staphylococcus aureus. J. Biol. Chem. 277, 47636–47644 (2002).
  CAS PubMed Google Scholar
• Collins, L. V. et al. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J. Infect. Dis. 186, 214–219 (2002).
  CAS PubMed Google Scholar
• Midorikawa, K. et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, β-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 71, 3730–3739 (2003).
  CAS PubMed PubMed Central Google Scholar
• Weidenmaier, C. et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nature Med. 10, 243–245 (2004).
  CAS PubMed Google Scholar
• Harder, J., Bartels, J., Christophers, E. & Schroder, J. M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707–5713 (2001).
  CAS PubMed Google Scholar
• Shafer, W. M., Casey, S. G. & Spitznagel, J. K. Lipid A and resistance of Salmonella typhimurium to antimicrobial granule proteins of human neutrophil granulocytes. Infect. Immun. 43, 834–838 (1984).
  CAS PubMed PubMed Central Google Scholar
• Guo, L. et al. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95, 189–198 (1998).
  CAS PubMed Google Scholar
• Vuong, C. et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6, 269–275 (2004).
  CAS PubMed Google Scholar
• Otto, M. Bacterial evasion of antimicrobial peptides by biofilm formation. Curr. Top. Microbiol. Immunol. 306, 251–258 (2006).
  CAS PubMed Google Scholar
• Ginsburg, I. The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae. APMIS 110, 753–770 (2002).
  PubMed Google Scholar
• Breukink, E. et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 2361–2364 (1999).
  CAS PubMed Google Scholar
• Wiedemann, I. et al. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276, 1772–1779 (2001). This article demonstrates the combination of several antimicrobial mechanisms in the antimicrobial peptide nisin.
  CAS PubMed Google Scholar
• Bierbaum, G. & Sahl, H. G. Induction of autolysis of staphylococci by the basic peptide antibiotic pep5 and nisin and their influence on the activity of autolytic enzymes. Arch. Microbiol. 141, 249–254 (1985).
  CAS PubMed Google Scholar
• Pag, U. & Sahl, H. G. Multiple activities in lantibiotics — models for the design of novel antibiotics? Curr. Pharm. Des. 8, 815–833 (2002).
  CAS PubMed Google Scholar
• Gravesen, A., Jydegaard Axelsen, A. M., Mendes, d. S., Hansen, T. B. & Knochel, S. Frequency of bacteriocin resistance development and associated fitness costs in Listeria monocytogenes. Appl. Environ. Microbiol. 68, 756–764 (2002).
  CAS PubMed PubMed Central Google Scholar
• Ganz, T. Hepcidin in iron metabolism. Curr. Opin. Hematol. 11, 251–254 (2004).
  CAS PubMed Google Scholar
• Nguyen, T. X., Cole, A. M. & Lehrer, R. I. Evolution of primate θ-defensins: a serpentine path to a sweet tooth. Peptides 24, 1647–1654 (2003).
  CAS PubMed Google Scholar
• Fowler, V. G. Jr et al. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190, 1140–1149 (2004).
  CAS PubMed Google Scholar
• Fowler, V. G. Jr et al. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J. Infect. Dis. 182, 1251–1254 (2000).
  CAS PubMed Google Scholar
• Frantz, S. Drug discovery: playing dirty. Nature 437, 942–943 (2005).
  CAS PubMed Google Scholar
• Arthur, M., Reynolds, P. & Courvalin, P. Glycopeptide resistance in enterococci. Trends Microbiol. 4, 401–407 (1996).
  CAS PubMed Google Scholar
• Allen, N. E. & Nicas, T. I. Mechanism of action of oritavancin and related glycopeptide antibiotics. FEMS Microbiol. Rev. 26, 511–532 (2003).
  CAS PubMed Google Scholar
• Zhang, H. Z., Hackbarth, C. J., Chansky, K. M. & Chambers, H. F. A proteolytic transmembrane signaling pathway and resistance to β-lactams in staphylococci. Science 291, 1962–1965 (2001).
  CAS PubMed Google Scholar
• Bader, M. W. et al. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122, 461–472 (2005). This article characterizes the first bacterial CAMP-sensing regulation system.
  CAS PubMed Google Scholar
• Jacoby, G. A. & Munoz-Price, L. S. The new β-lactamases. N. Engl. J. Med. 352, 380–391 (2005).
  CAS PubMed Google Scholar
• Hiramatsu, K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1, 147–155 (2001).
  CAS PubMed Google Scholar
• van Veen, H. W. & Konings, W. N. Drug efflux proteins in multidrug resistant bacteria. Biol. Chem. 378, 769–777 (1997).
  CAS PubMed Google Scholar
• Fux, C. A., Costerton, J. W., Stewart, P. S. & Stoodley, P. Survival strategies of infectious biofilms. Trends Microbiol. 13, 34–40 (2005).
  CAS PubMed Google Scholar